Study in The Lancet successfully demonstrated endpoints of identifying both vulnerable patients & plaques at a significantly higher risk for subsequent MACE. View now View Now

Clinical Evidence

The evidence is clear. There have been multiple studies published showinghow NIRS-identified Lipid Core Plaque is clinically shown to predict MACE.

LRP: Assessment of Coronary Near-Infrared Spectroscopy Imaging to Detect Vulnerable Plaques and Vulnerable Patients

Near-Infrared Spectroscopy Predicts Cardiovascular Outcome in Patients with Coronary Artery Disease

Oemrawsingh RM, Cheng JM, García-García HM, et al

CONCLUSION:
Oemrawsingh RM, Cheng JM, García-García HM, et al

J Am Coll Cardiol. 2014 Dec 16;64(23):2510-8.

Large Lipid-Rich Coronary Plaques Detected by Near-Infrared Spectroscopy at Non-Stented Sites in the Target Artery Identify Patients Likely to Experience Future Major Adverse Cardiovascular Events

Madder RD, Husaini M, Davis AT, et al.

CONCLUSION:
Madder RD, Husaini M, Davis AT, et al.

Eur Heart J Cardiovasc Imaging. 2016 Apr;17(4):393-9.

Near-Infrared Spectroscopy-Derived Lipid Core Burden Index Predicts Adverse Cardiovascular Outcome in Patients with Coronary Artery Disease During Long-Term Follow-Up

Schuurman A-S, Vroegindewey M, Kardys I, et al.

CONCLUSION:
Schuurman A-S, Vroegindewey M, Kardys I, et al.

Eur Heart J 2017; ehx247, Epub ahead of print.

Long-Term Follow-Up after Near-Infrared Spectroscopy Coronary Imaging: Insights From the Lipid Core Plaque Association with Clinical Events (ORACLE-NIRS) Registry

Danek BA, Karatasakis A, Karacsonyi J, et al.

CONCLUSION:
Danek BA, Karatasakis A, Karacsonyi J, et al.

Cardiovasc Revascularization Med Mol Interv 2017;18(3):177–81.

© 2019 Infraredx™, Inc. All Rights Reserved Powered by Bloom Creative